Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 126-150 of 606 matching filings.

Per page
25
Current page
6
4

FORM 4

Filing date
22 Feb 2024
Reporting date
20 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Feb 2024
Reporting date
20 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Feb 2024
Reporting date
20 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
22 Feb 2024
Reporting date
02 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
22 Feb 2024
Reporting date
02 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
22 Feb 2024
Reporting date
02 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88628

SC 13G filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88628

SC 13G/A filing

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Sep 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
22 Sep 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Aug 2023
Reporting date
18 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
21 Aug 2023
Reporting date
18 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Aug 2023
Reporting date
18 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
21 Aug 2023
Reporting date
18 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PX14A6G File 001-36421

PX14A6G filing

Filing date
06 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .